A small molecule differentiation inducer increases insulin production by pancreatic β cells

Elhadji M. Dioum, Jihan K. Osborne, Sean Goetsch, Jamie Russell, Jay W. Schneider, Melanie H. Cobb

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

New drugs for preserving and restoring pancreatic β-cell function are critically needed for the worldwide epidemic of type 2 diabetes and the cure for type 1 diabetes. We previously identified a family of neurogenic 3,5-disubstituted isoxazoles (Isx) that increased expression of neurogenic differentiation 1 (NeuroD1, also known as BETA2); this transcription factor functions in neuronal and pancreatic β-cell differentiation and is essential for insulin gene transcription. Here, we probed effects of Isx on human cadaveric islets and MIN6 pancreatic β cells. Isx increased the expression and secretion of insulin in islets that made little insulin after prolonged ex vivo culture and increased expression of neurogenic differentiation 1 and other regulators of islet differentiation and insulin gene transcription. Within the first few hours of exposure, Isx caused biphasic activation of ERK1/2 and increased bulk histone acetylation. Although there was little effect on histone deacetylase activity, Isx increased histone acetyl transferase activity in nuclear extracts. Reconstitution assays indicated that Isx increased the activity of the histone acetyl transferase p300 through an ERK1/2-dependent mechanism. In summary, we have identified a small molecule with antidiabetic activity, providing a tool for exploring islet function and a possible lead for therapeutic intervention in diabetes.

Original languageEnglish (US)
Pages (from-to)20713-20718
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number51
DOIs
StatePublished - Dec 20 2011

Fingerprint

Isoxazoles
Insulin
Histones
Transferases
Histone Deacetylases
Essential Genes
Acetylation
Type 1 Diabetes Mellitus
Islets of Langerhans
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Cell Differentiation
Transcription Factors
Pharmaceutical Preparations
Genes

Keywords

  • Differentiation
  • Glucose-stimulated insulin secretion
  • Human islets
  • p300

ASJC Scopus subject areas

  • General

Cite this

A small molecule differentiation inducer increases insulin production by pancreatic β cells. / Dioum, Elhadji M.; Osborne, Jihan K.; Goetsch, Sean; Russell, Jamie; Schneider, Jay W.; Cobb, Melanie H.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 51, 20.12.2011, p. 20713-20718.

Research output: Contribution to journalArticle

@article{78188edd308e4eb6a0fe75f2d2b30908,
title = "A small molecule differentiation inducer increases insulin production by pancreatic β cells",
abstract = "New drugs for preserving and restoring pancreatic β-cell function are critically needed for the worldwide epidemic of type 2 diabetes and the cure for type 1 diabetes. We previously identified a family of neurogenic 3,5-disubstituted isoxazoles (Isx) that increased expression of neurogenic differentiation 1 (NeuroD1, also known as BETA2); this transcription factor functions in neuronal and pancreatic β-cell differentiation and is essential for insulin gene transcription. Here, we probed effects of Isx on human cadaveric islets and MIN6 pancreatic β cells. Isx increased the expression and secretion of insulin in islets that made little insulin after prolonged ex vivo culture and increased expression of neurogenic differentiation 1 and other regulators of islet differentiation and insulin gene transcription. Within the first few hours of exposure, Isx caused biphasic activation of ERK1/2 and increased bulk histone acetylation. Although there was little effect on histone deacetylase activity, Isx increased histone acetyl transferase activity in nuclear extracts. Reconstitution assays indicated that Isx increased the activity of the histone acetyl transferase p300 through an ERK1/2-dependent mechanism. In summary, we have identified a small molecule with antidiabetic activity, providing a tool for exploring islet function and a possible lead for therapeutic intervention in diabetes.",
keywords = "Differentiation, Glucose-stimulated insulin secretion, Human islets, p300",
author = "Dioum, {Elhadji M.} and Osborne, {Jihan K.} and Sean Goetsch and Jamie Russell and Schneider, {Jay W.} and Cobb, {Melanie H.}",
year = "2011",
month = "12",
day = "20",
doi = "10.1073/pnas.1118526109",
language = "English (US)",
volume = "108",
pages = "20713--20718",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "51",

}

TY - JOUR

T1 - A small molecule differentiation inducer increases insulin production by pancreatic β cells

AU - Dioum, Elhadji M.

AU - Osborne, Jihan K.

AU - Goetsch, Sean

AU - Russell, Jamie

AU - Schneider, Jay W.

AU - Cobb, Melanie H.

PY - 2011/12/20

Y1 - 2011/12/20

N2 - New drugs for preserving and restoring pancreatic β-cell function are critically needed for the worldwide epidemic of type 2 diabetes and the cure for type 1 diabetes. We previously identified a family of neurogenic 3,5-disubstituted isoxazoles (Isx) that increased expression of neurogenic differentiation 1 (NeuroD1, also known as BETA2); this transcription factor functions in neuronal and pancreatic β-cell differentiation and is essential for insulin gene transcription. Here, we probed effects of Isx on human cadaveric islets and MIN6 pancreatic β cells. Isx increased the expression and secretion of insulin in islets that made little insulin after prolonged ex vivo culture and increased expression of neurogenic differentiation 1 and other regulators of islet differentiation and insulin gene transcription. Within the first few hours of exposure, Isx caused biphasic activation of ERK1/2 and increased bulk histone acetylation. Although there was little effect on histone deacetylase activity, Isx increased histone acetyl transferase activity in nuclear extracts. Reconstitution assays indicated that Isx increased the activity of the histone acetyl transferase p300 through an ERK1/2-dependent mechanism. In summary, we have identified a small molecule with antidiabetic activity, providing a tool for exploring islet function and a possible lead for therapeutic intervention in diabetes.

AB - New drugs for preserving and restoring pancreatic β-cell function are critically needed for the worldwide epidemic of type 2 diabetes and the cure for type 1 diabetes. We previously identified a family of neurogenic 3,5-disubstituted isoxazoles (Isx) that increased expression of neurogenic differentiation 1 (NeuroD1, also known as BETA2); this transcription factor functions in neuronal and pancreatic β-cell differentiation and is essential for insulin gene transcription. Here, we probed effects of Isx on human cadaveric islets and MIN6 pancreatic β cells. Isx increased the expression and secretion of insulin in islets that made little insulin after prolonged ex vivo culture and increased expression of neurogenic differentiation 1 and other regulators of islet differentiation and insulin gene transcription. Within the first few hours of exposure, Isx caused biphasic activation of ERK1/2 and increased bulk histone acetylation. Although there was little effect on histone deacetylase activity, Isx increased histone acetyl transferase activity in nuclear extracts. Reconstitution assays indicated that Isx increased the activity of the histone acetyl transferase p300 through an ERK1/2-dependent mechanism. In summary, we have identified a small molecule with antidiabetic activity, providing a tool for exploring islet function and a possible lead for therapeutic intervention in diabetes.

KW - Differentiation

KW - Glucose-stimulated insulin secretion

KW - Human islets

KW - p300

UR - http://www.scopus.com/inward/record.url?scp=84855512177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855512177&partnerID=8YFLogxK

U2 - 10.1073/pnas.1118526109

DO - 10.1073/pnas.1118526109

M3 - Article

C2 - 22143803

AN - SCOPUS:84855512177

VL - 108

SP - 20713

EP - 20718

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 51

ER -